PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15724152

Pharmaceutical counterfeiting.

Anil K Deisingh
View original source ↗Export metadata ↓

Abstract

Pharmaceutical counterfeiting is becoming a serious problem both in developed and developing countries. This paper considers the extent of the problem and provides several examples of drugs which have been counterfeited. Additionally, the effects of counterfeit products on consumers, health care providers, drug manufacturers and governments are discussed. Several of the currently used methods of detection are described and these include near-infrared spectroscopy, Raman spectroscopy, isotopic characterization, tensiography, chromatographic and mass spectrometric approaches. Finally, anti-counterfeiting measures such as the use of holograms, tracers and taggants and electronic tracking are summarized.

Explore related subjects

Consumer Product SafetyDrug IndustryDrug and Narcotic ControlFraudHumansPharmaceutical PreparationsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Anil K Deisingh. 2004-12-14. Pharmaceutical counterfeiting.. https://doi.org/10.1039/b407759h

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

The role of processing on ochratoxin A content in Italian must and wine: a study on naturally contaminated grapes.

Available data show that ochratoxin A (OTA) is a possible contaminant of wine and its concentration is higher in red wines than in white and rosé. The aim of this work was to study the fate of OTA during the main stages of the winemaking process (crushing, maceration, alcoholic fermentation, malo-lactic fermentation, bottle-aging) and the influence of technological treatments on OTA concentration in order to identify the critical process steps. Attention was focused on red winemaking, in different wineries in the south of Italy, with two naturally OTA contaminated grape varieties ('Negroamaro' and 'Primitivo') and on different vintages (2001-2002-2003). The results show that no OTA is produced during winemaking, but each operation during winemaking can modify OTA content. The OTA present in grapes to a certain degree is released to the juice during crushing. Maceration increases the OTA content, while alcoholic and malo-lactic fermentation cause a reduction in OTA in the wine.

Consumer Product Safety↗
PubMed2006

Product quality-based eco-efficiency applied to digital cameras.

When calculating eco-efficiency, there are considerable confusion and controversy about what the product value is and how it should be quantified. We have proposed here a quantification method for eco-efficiency that derives the ratio of the multiplication value of the product quality and the life span of a product to its whole environmental impact based on Life Cycle Assessment (LCA). In this study, product quality was used as the product value and quantified by the following three steps: (1) normalization based on a value function, (2) determination of the subjective weighting factors of the attributes, and (3) calculation of product quality of the chosen products. The applicability of the proposed method to an actual product was evaluated using digital cameras. The results show that the eco-efficiency values of products equipped with rechargeable batteries were higher than those products that use alkaline batteries, because of higher quality values and lower environmental impacts. The sensitivity analysis shows that the proposed method was superior to the existing methods, because it enables to identify the quality level of the chosen products by considering all products that have the same functions in the market and because, when adding a new product, the calculated quality values in the proposed method do not have to be changed.

Consumer Product Safety↗
PubMed2006

A new method using a health index (HI) to screen low level toxic organic substances in consumer products.

To ensure selection of appropriate materials for industrial use in terms of toxicity, a procedure to estimate a health index (HI) that can be used for prioritizing less hazardous components of consumer products is described. The HI is based on the occupational exposure limits (OELs) of organic substances that compose the products. To calculate the HI of a product, it is often necessary to predict OEL values for the substances for which an OEL value has not yet been promulgated. We developed a method to estimate the OEL values from median lethal dose (LD50) data of rodent. A good correlation between known OEL values and the LD50 data was obtained by a multivariate regression analysis by introducing organic compensation coefficients, which were caluculated as 10 to the Bth power where B is the regression coefficient of dummy variables denoting the characteristics of the organic compounds such as functional groups, molecular structures, and so on. We believe that the use of the present method should be limited to predicting unknown OEL values for the HI and used for material prioritization. It should not be extended to determinations of regulatory OELs.

Consumer Product Safety↗